Mutational Status of the TP53 Gene As a Predictor of Response and Survival in Patients With Chronic Lymphocytic Leukemia: Results From the LRF CLL4 Trial

D. Gonzalez, P. Martinez, R. Wade, S. Hockley, D. Oscier, E. Matutes, C.E. Dearden, S.M. Richards, D. Catovsky, G.J. Morgan

Research output: Contribution to journalArticlepeer-review

195 Citations (Scopus)

Fingerprint Dive into the research topics of 'Mutational Status of the TP53 Gene As a Predictor of Response and Survival in Patients With Chronic Lymphocytic Leukemia: Results From the LRF CLL4 Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences